CELMA MASTRY OVARIAN CANCER FOUNDATION (EIN 331023477) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

Claudette Carlan

Phone

8633812034

Tax Period

2024-01-01 to 2024-12-31

CELMA MASTRY OVARIAN CANCER FOUNDATION, founded in 2003, is a small nonprofit in the Diseases & Disorders sector that reported $353K in total revenue in fiscal year 2024. Revenue surged 102% from the prior year, signaling strong growth momentum. The organization ran a surplus of $132K, a strong 37% operating margin.

Mission

to unite community, friends and family to fight ovarian cancer and our goals,which are , sponsor research, assist in the devolpment of an early detection test, and in preventionn , educate the community and offer financial assistance to patients in need.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $280,569

Program Service Revenue $0

Investment Income $42,437

Other Revenue $30,435

TOTAL REVENUE $353,441

Expense Breakdown

Grants Paid $151,000

Salaries & Benefits $0

Fundraising Expenses $18,332

Program Expenses $151,000

Other Expenses $70,727

TOTAL EXPENSES $221,727

Year-over-Year Comparison

	2024	2023	Change
Revenue	$353,441	$175,206	+1.0%
Expenses	$221,727	$215,604	+0.0%
Net Income	$131,714	$-40,398	-4.3%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
Claudette Carlan	President	Officer Director	$0	$0	$0
DR MICHEAL G MASTRY	Vice President	Officer Director	$0	$0	$0
JULIE MASTRY	Secretary	Officer Director	$0	$0	$0
CONSTANTINE E MASTRY	Treasurer	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$353,441	$221,727	$1,085,067	$131,714
2023	$175,206	$215,604	$953,353	$-40,398
2022	$132,096	$200,743	$993,751	$-68,647
2021	$593,867	$109,027	$1,062,398	$484,840
2020	$109,423	$88,787	$577,557	$20,636
2019	$282,424	$184,753	$556,920	$97,671
2018	$207,883	$138,492	$459,251	$69,391

CELMA MASTRY OVARIAN CANCER FOUNDATION